Mergers & Acquisitions - Generics, Perrigo

Filter

Current filters:

GenericsPerrigo

Popular Filters

Perrigo acquires ophthalmic portfolio from Fera Pharma for initial $93 million

18-06-2013

Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed…

Fera PharmaceuticalsGenericsMergers & AcquisitionsOphthalmicsPerrigo

Perrigo acquires UK drugmaker Rosemont for £180 million

12-02-2013

USA-based Perrigo (Nasdaq: PRGO) has signed a definitive merger agreement and has completed the acquisition…

GenericsMergers & AcquisitionsPerrigoPharmaceuticalRosemont Pharmaceuticals

Perrigo buys full control of Cobrek Pharma for about $45 million

31-12-2012

US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger…

Cobrek PharmaceuticalsGenericsMergers & AcquisitionsPerrigoPharmaceutical

Impax in deal with Perrigo; Cipla eyes South Africa acquisition

22-11-2012

Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker…

CiplaCipla MedproGenericsImpax LaboratoriesMarkets & MarketingMergers & AcquisitionsNorth AmericaPerrigoResearchRest of the World

Company Spotlight

ImmunoGen

ImmunoGen

Back to top